Search filters

List of works by Paolo Lissoni

A Reinterpretation of the Pathogenesis and Cure of Cancer According to the Psychoneuroimmunological Discoveries

scientific article published on January 1, 2012

A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone

scientific article

A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.

scientific article

A study of individual behaviour in age-related decline in the pineal secretion of melatonin: possible implications in the prevention of age-related human diseases

scholarly article

Cancer as the Main Aging Factor for Humans: The Fundamental Role of 5-Methoxy-Tryptamine in Reversal of Cancer-Induced Aging Processes in Metabolic and Immune Reactions by Non-melatonin Pineal Hormones

scientific article published on December 1, 2012

Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.

scientific article

Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.

scientific article

Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline

scientific article published on 01 March 2002

Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia.

scientific article published in January 2000

Endocrine effects of erythropoietin in cancer patients

scientific article

Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients.

scientific article

Evidence for a neuroimmunomodulatory and a hematopoietic role of the Luschka's coccygeal body(3).

scientific article published in January 2000

Evidence of pineal endocrine hypofunction in autistic children

scientific article published in January 2000

Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin

scientific article

HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer

scientific article published on 01 November 2009

How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases

scientific article published on 01 January 2018

Malignancy: Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical Response

scientific article published on 01 January 2000

Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.

scientific article published in March 2008

Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system

scientific article published in August 2002

Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone.

scientific article published on January 2000

Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity.

scientific article published in March 2010

Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patients.

scientific article published in January 2002

Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.

scientific article

Principles of Psychoneuroendocrinoimmunotherapy of Cancer

scientific article published on January 1, 2012

Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis

scientific article published on December 1, 2012

Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin

scientific article published on September 1, 2010

Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients

scientific article published on February 1, 2003

Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients

scientific article published on February 1, 2003

Relationship between psychoncology and psychoneuroendocrinoimmunology (PNEI): enhanced T-regulatory lymphocyte activity in cancer patients with self-punishement, evaluated by Rorschach test.

scientific article published in January 2010

Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.

scientific article published in March 2010

The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation.

scientific article published on November 2008

The pineal gland as a central regulator of cytokine network

scientific article published on 01 January 1999

The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results

scientific article published on 26 April 2017

The role of IL-17 secretion in mediating the influence of stress on cancer and other human systemic diseases

scholarly article

Therapy implications of the role of interleukin-2 in cancer

scientific article published on 26 October 2016

Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study

scientific article published on June 1, 2003